RECIPE: Reduction of Postoperative Wound Infections by Antiseptica?

Sponsor
Johannes Lauscher (Other)
Overall Status
Completed
CT.gov ID
NCT04055233
Collaborator
(none)
456
1
2
44.6
10.2

Study Details

Study Description

Brief Summary

Wound infections are a frequent complication in abdominal surgery. The investigators hypothesize that the antiseptic solution 0.04 % polyhexanide (serasept) may reduce occurrence of postoperative wound infections compared to NaCL (saline) solution in a prospective randomized setting.

Condition or Disease Intervention/Treatment Phase
  • Drug: Polihexanide; Serasept
  • Drug: NaCl; saline
Phase 3

Detailed Description

Invstigator initiated monocenter randomized controlled trial. Intraoperative irrigation of subcutaneous tissue with NaCl (saline) solution or antiseptic solution 0.04 % polyhexanide (Serasept) in elective abdominal surgery. Primary endpoint: SSI 30 days postoperatively according to CDC criteria.

Study Design

Study Type:
Interventional
Actual Enrollment :
456 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two arm prospective randomized single center interventional trial. 1:1 randomization into experimental arm (irrigation with polyhexanide) and control arm (irrigation with saline).Two arm prospective randomized single center interventional trial. 1:1 randomization into experimental arm (irrigation with polyhexanide) and control arm (irrigation with saline).
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Reduction of Postoperative Wound Infections by Antiseptica?
Actual Study Start Date :
Feb 1, 2015
Actual Primary Completion Date :
Sep 10, 2018
Actual Study Completion Date :
Oct 20, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Subcutaneous irrigation with 0.04% polyhexanide solution

Intervention: after closure of abdominal fascia, an intraoperative irrigation of the subcutaneous tissue with 250 ml antiseptic solution (0.04% polyhexanide) will be done once for ten minutes. No subcutaneous suture. Closure of skin with either staples, interrupted sutures or running suture.

Drug: Polihexanide; Serasept
Experimental arm: irrigation of subcutaneous tissue after fascia closure with polihexanide (ten minutes). A single dose of perioperative antibiotics (cefuroxim alone or cefuroxim and metrodidazole in bowel surgeries) was given 30 minutes before skin incision. Hair removal was done with electronic clippers and preoperative skin antisepsis was performed with propanol and povidone-iodine. Before closure of fascia, instruments and gloves were changed. No subcutaneous suture was used. Skin was closed either with skin staples, continuous intracutaneous suture or interrupted suture. All surgeries were done according to the Standard Operating Procedures of the Department for General, Visceral and Vascular Surgery, Charité Campus Benjamin Franklin.
Other Names:
  • Polihexanide (0.04% antiseptic solution)
  • Active Comparator: Subcutaneous irrigation with NaCl (saline)

    Intervention: after closure of fascia, an intraoperative irrigation of the subcutaneous tissue with 250 ml NaCl (saline) will be done once for one minute. No subcutaneous suture. Closure of skin with either staples, interrupted sutures or running suture.

    Drug: NaCl; saline
    Control arm: irrigation of subcutaneous tissue after fascia closure with NaCl (one minute) A single dose of perioperative antibiotics (cefuroxim alone or cefuroxim and metrodidazole in bowel surgeries) was given 30 minutes before skin incision. Hair removal was done with electronic clippers and preoperative skin antisepsis was performed with propanol and povidone-iodine. All surgeries were done according to the Standard Operating Procedures of the Department for General, Visceral and Vascular Surgery, Charité Campus Benjamin Franklin. Before closure of fascia, instruments and gloves were changed. No subcutaneous suture was used. Skin was closed either with skin staples, continuous intracutaneous suture or interrupted suture. All surgeries were done according to the Standard Operating Procedures of the Department for General, Visceral and Vascular Surgery, Charité Campus Benjamin Franklin.
    Other Names:
  • NaCl (saline)
  • Outcome Measures

    Primary Outcome Measures

    1. surgical site infection [30 days postoperatively]

      Surgical site infection according to CDC definition.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria: - planned laparotomy for visceral surgery

    Exclusion Criteria:
    • Age under 18 years

    • allergy against polihexanid

    • laparoscopic surgery

    • emergency surgery

    • lack of understanding of the trial

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Charité Campus Benjamin Franklin Berlin-Steglitz Berlin Germany 12200

    Sponsors and Collaborators

    • Johannes Lauscher

    Investigators

    • Principal Investigator: Johannes C Lauscher, MD, Charité-University Medicine (Berlin, Germany)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Johannes Lauscher, Principal investigator, MD, PhD, Staff surgeon, Department of General, Visceral and Vascular Surgery, Charite University, Berlin, Germany
    ClinicalTrials.gov Identifier:
    NCT04055233
    Other Study ID Numbers:
    • 2014-001551-22
    First Posted:
    Aug 13, 2019
    Last Update Posted:
    Aug 13, 2019
    Last Verified:
    Aug 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 13, 2019